Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 25.11B | 23.18B | 21.31B | 19.19B | 16.74B |
Gross Profit | 14.21B | 14.76B | 13.99B | 12.99B | 11.42B |
EBITDA | 1.40B | 3.27B | 3.35B | 4.21B | 3.47B |
Net Income | -461.80M | 1.27B | 1.42B | 2.14B | 1.66B |
Balance Sheet | |||||
Total Assets | 33.67B | 31.49B | 29.43B | 27.34B | 25.19B |
Cash, Cash Equivalents and Short-Term Investments | 3.18B | 2.32B | 2.80B | 2.59B | 2.47B |
Total Debt | 3.29B | 1.49B | 1.87B | 1.85B | 3.09B |
Total Liabilities | 8.93B | 5.88B | 6.14B | 5.85B | 6.48B |
Stockholders Equity | 24.68B | 25.51B | 23.16B | 21.39B | 18.63B |
Cash Flow | |||||
Free Cash Flow | -504.10M | 302.45M | 870.67M | 1.53B | 1.23B |
Operating Cash Flow | 1.05B | 2.10B | 2.19B | 3.11B | 2.60B |
Investing Cash Flow | -1.67B | -1.80B | -1.48B | -1.75B | -1.35B |
Financing Cash Flow | 1.49B | -840.71M | -514.78M | -1.29B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | ¥14.38B | 10.23 | 2.81% | 4.84% | -148.94% | ||
51 Neutral | $7.37B | 0.24 | -62.86% | 2.36% | 15.01% | -2.64% | |
― | $177.63M | ― | -184.59% | ― | ― | ― | |
78 Outperform | ¥8.88B | 11.89 | 3.74% | 3.38% | 88.65% | ||
77 Outperform | ¥13.46B | 10.64 | 2.05% | 13.54% | 78.47% | ||
75 Outperform | ¥8.31B | 10.75 | 2.04% | 11.24% | 53.32% | ||
74 Outperform | ¥16.45B | 15.78 | 3.56% | 5.92% | 8.59% |
Japan Medical Dynamic Marketing, Inc. reported a decline in its financial performance for the first quarter of the fiscal year ending March 2026, with significant drops in net sales, operating profit, and profit attributable to owners of the parent compared to the previous year. Despite the downturn, the company maintains a strong capital adequacy ratio and has not revised its financial forecasts, suggesting a cautious optimism about future performance.
Japan Medical Dynamic Marketing, Inc. announced its relationship with Mitsui Chemicals, Inc., highlighting a capital and business alliance aimed at expanding their operations in the medical device field. Despite Mitsui Chemicals’ significant voting rights, Japan Medical Dynamic Marketing maintains operational independence, ensuring no restrictions on its business activities, which supports its strategic growth and industry positioning.